Righteous indignation
is typically a reactive emotion
of anger over perceived
mistreatment, insult, or malice. It is akin to what is called the sense of injustice. In
some Christian
doctrines, righteous indignation is considered the only form of anger that is
not sinful.
ReginaHolliday, the
Walking Gallery, just completed this amazing jacket for my brother, Steven
Baker. "Don't Tell Me To Zip It!"
What you see in our eyes is not disappointment,
but righteous indignation!
The righteous indignation stems from research (my
blog is an aggregate of that research) that easily uncovers a continuing
systemic abuse of our government by elements of the entitled implanted medical
device industry. The indicators
are patient harm (mutilation, torture) and futile class action lawsuits that do
not stop the perpetrators from exploiting others.
This morning the Senate Medical Technology
Caucus was briefed (with the
FDA/CDRH) about the new “Medical Device
Innovation Consortium” an unnecessary and redundant platform for the industry
to influence regulators and legislators.
Patients are the primary stakeholders. Patient
engagement is a term that is not being honored. I am witness as a patient advocate who has dedicated much of
my life the last 5 years to following protocol to determine why my brother’s
elbow implant failed and to get him the care that he needs. It is clear to me that our
government (FDA) is unable to assure that implants are safe and effective and
subsequently unable to provide justice/assistance to correct the system so this
does not happen to others.
The cost of this failure to U.S. healthcare
consumers is staggering, but the profit of the device industry is driving exploitive
legislation and status quo medical practice. Public education and public indignation is coming. Ethical CEO’s must get out in front and
lead the US medical device industry to embrace patient adverse event reports as
an essential, timely mechanism to improve product.
Dear
MDIC founders,
"Maura Donovan, PhD"
<maura.donovan@medtronic.com>
Dale
Wahlstrom <dwahlstrom@biobusinessalliance.org>
Please
accept this as my application for MDIC membership. Please waive the $5000
annual fee. I represent patients harmed by failed implants with the goal
of making implants safer and more effective. FDA/OSHI has interviewed me,
I attended a FDA Patient Representative workshop and testified at 2 CDRH Town
Hall meetings and the first MDUFA meeting 1/2011. I understand that MDIC
is interested in inclusion of all stakeholders in this new 501(c)3 nonprofit
partnership. I look forward to working with you.
http://www.washingtonpost.com/business/technology/fda-pledges-to-work-with-medical-device-industry-consortium-to-speed-up-product-approvals/2012/12/03/0c9e4c10-3d64-11e2-8a5c-473797be602c_story.html
By Associated Press, Updated: Monday,
December 3, 10:11 AM
WASHINGTON — The Food and Drug Administration
says it will collaborate with medical device manufacturers on a public-private
partnership designed to speed up the development of new medical technology.
The agency says it hopes to offer guidance to the
Medical Device Innovation Consortium, a new industry-backed group that aims to
simplify the design and testing of medical devices.
Medical device makers have criticized the FDA for
an overly burdensome review process, which they claim slows down development of
important new therapies. Congressional Republicans have held several hearings
to scrutinize the agency’s system.
Faced with criticism from industry and Capitol
Hill, the FDA has been highlighting efforts to slash red tape and accelerate
review times.
The new consortium was created by LifeScience
Alley, a Minnesota-based industry group that includes leading manufacturer
Medtronic Inc.
No comments:
Post a Comment